Loading…
Loading…
I downgrade iShares MSCI Philippines ETF (EPHE) from buy to hold due to deteriorating GDP growth, a hawkish interest rate environment, unsteady foreign remittances and weak earnings prospects. EPHE trades at a compelling 8.75x forward P/E, but its long-term earnings growth outlook is only 3%, far below diversified EM peers. Philippines' central bank is in a hawkish cycle as inflation readings remain over 2x more than its comfort range, pressuring economic recovery.
The iShares MSCI Philippines ETF trades at a low 9.6x P/E, offering relative value among ASEAN peers despite macro headwinds. EPHE is heavily indexed to International Container Terminal Services (21.4%) and financials, making it exposed to trade flows and macro conditions. High oil prices are an FX threat, as a lot of selling needs to be done to cover USD-denominated barrels. It's also a concrete economic scarcity.
Countries around the world have scrambled to cope with the fallout of the energy shock from the Iran war. This comes as the Iran war stretches into its third week.
ASEAN's dividend opportunity is underpinned by diverse and evolving market characteristics. The FTSE ASEAN Index, which captures the large- and mid-cap companies listed in the five ASEAN markets - Singapore, Malaysia, Indonesia, Thailand and Philippines - has delivered a 10-year average dividend yield of 3.57%. Across multiple market cycles over the past 25 years, a back-test of the FTSE ASEAN ex REITs Target Dividend Index's strategy showed notable resilience during market downturns and lower overall volatility compared with the broader ASEAN market.
The iShares MSCI Philippines ETF is rated Buy, driven by deeply discounted valuations and an improving macroeconomic outlook. EPHE trades at a 9.3x PE, the second lowest globally and well below its historical averages, suggesting substantial upside potential. The Philippines GDP growth is forecasted at 5.4–5.7% for 2026, with strong domestic demand and accommodative monetary policy supporting the investment case.
Healthcare and biotech led last week's winners, with EPHE, BBC, HELX, XHS and SURI topping ETF gains as markets slid on AI worries and Fed uncertainty.
iShares MSCI Philippines ETF stands out as a compelling value play amid globally stretched valuations. U.S. and other developed markets appear fully priced, while emerging markets, especially the Philippines, offer attractive P/E ratios. EPHE provides exposure to the Philippines, currently one of the world's cheapest markets by P/E, suggesting strong relative value.
Philippines' macro backdrop is improving, with accelerating GDP growth, easing inflation, and supportive monetary policy likely to boost EPHE's prospects. EPHE offers compelling value, trading at deep discounts to peers on both earnings and cash flow, alongside a decent yield above most Asian and global markets. Industrial sector recovery and favorable export conditions further support the ETF, while technicals suggest mean reversion potential after prolonged underperformance.